Norman David Eansor - Net Worth and Insider Trading

Norman David Eansor Net Worth

The estimated net worth of Norman David Eansor is at least $1 Million dollars as of 2024-11-13. Norman David Eansor is the President-Protein Sciences of Bio-Techne Corp and owns about 8,468 shares of Bio-Techne Corp (TECH) stock worth over $630,019. Norman David Eansor is the President Bioproducts of Cambrex Corp and owns about 6,298 shares of Cambrex Corp (CBM) stock worth over $377,817. Norman David Eansor is also the Director of Marker Therapeutics Inc and owns about 1,671 shares of Marker Therapeutics Inc (MRKR) stock worth over $6,216. Details can be seen in Norman David Eansor's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Norman David Eansor has not made any transactions after 2021-11-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Norman David Eansor

To

Norman David Eansor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Norman David Eansor owns 2 companies in total, including Bio-Techne Corp (TECH) , and Marker Therapeutics Inc (MRKR) .

Click here to see the complete history of Norman David Eansor’s form 4 insider trades.

Insider Ownership Summary of Norman David Eansor

Ticker Comapny Transaction Date Type of Owner
TECH Bio-Techne Corp 2021-11-12 SVP Biotech
MRKR Marker Therapeutics Inc 2021-03-16 director

Norman David Eansor Latest Holdings Summary

Norman David Eansor currently owns a total of 3 stocks. Among these stocks, Norman David Eansor owns 8,468 shares of Bio-Techne Corp (TECH) as of November 12, 2021, with a value of $630,019 and a weighting of 62.13%. Norman David Eansor owns 6,298 shares of Cambrex Corp (CBM) as of January 6, 2006, with a value of $377,817 and a weighting of 37.26%. Norman David Eansor also owns 1,671 shares of Marker Therapeutics Inc (MRKR) as of March 16, 2021, with a value of $6,216 and a weighting of 0.61%.

Latest Holdings of Norman David Eansor

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TECH Bio-Techne Corp 2021-11-12 8,468 74.40 630,019
CBM Cambrex Corp 2006-01-06 6,298 59.99 377,817
MRKR Marker Therapeutics Inc 2021-03-16 1,671 3.72 6,216

Holding Weightings of Norman David Eansor


Norman David Eansor Form 4 Trading Tracker

According to the SEC Form 4 filings, Norman David Eansor has made a total of 6 transactions in Bio-Techne Corp (TECH) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Bio-Techne Corp is the sale of 108,636 shares on November 12, 2021, which brought Norman David Eansor around $14 Million.

According to the SEC Form 4 filings, Norman David Eansor has made a total of 0 transactions in Cambrex Corp (CBM) over the past 5 years. The most-recent trade in Cambrex Corp is the sale of 1,439 shares on January 6, 2006, which brought Norman David Eansor around $29,485.

According to the SEC Form 4 filings, Norman David Eansor has made a total of 1 transactions in Marker Therapeutics Inc (MRKR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Marker Therapeutics Inc is the acquisition of 1,429 shares on March 16, 2021, which cost Norman David Eansor around $249,988.

Insider Trading History of Norman David Eansor

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Norman David Eansor Trading Performance

GuruFocus tracks the stock performance after each of Norman David Eansor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Norman David Eansor is 75.27%. GuruFocus also compares Norman David Eansor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Norman David Eansor within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Norman David Eansor's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Norman David Eansor

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.22 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.6 LIMIT LIMIT LIMIT LIMIT LIMIT

Norman David Eansor Ownership Network

Ownership Network List of Norman David Eansor

No Data

Ownership Network Relation of Norman David Eansor

Insider Network Chart

Norman David Eansor Owned Company Details

What does Bio-Techne Corp do?

Who are the key executives at Bio-Techne Corp?

Norman David Eansor is the SVP Biotech of Bio-Techne Corp. Other key executives at Bio-Techne Corp include PRESIDENT & PROTEIN SCIENCES William Geist , director & Chief Executive Officer Charles R. Kummeth , and SVP - General Counsel Shane Bohnen .

Bio-Techne Corp (TECH) Insider Trades Summary

Over the past 18 months, Norman David Eansor made no insider transaction in Bio-Techne Corp (TECH). Other recent insider transactions involving Bio-Techne Corp (TECH) include a net sale of 80,322 shares made by Charles R. Kummeth , a net sale of 19,339 shares made by Roeland Nusse , and a net sale of 16,000 shares made by Robert V Baumgartner .

In summary, during the past 3 months, insiders sold 0 shares of Bio-Techne Corp (TECH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 119,661 shares of Bio-Techne Corp (TECH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 119,661 shares.

Bio-Techne Corp (TECH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bio-Techne Corp Insider Transactions

No Available Data

Norman David Eansor Mailing Address

Above is the net worth, insider trading, and ownership report for Norman David Eansor. You might contact Norman David Eansor via mailing address: 8100 Southpark Way, A-8, Littleton Co 80120.